sábado, 7 de agosto de 2021

Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts | Journal of Translational Medicine | Full Text

Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts | Journal of Translational Medicine | Full Text

No hay comentarios:

Publicar un comentario